Craig C. Hopkinson

Insider Reports History

Entity
Individual
Location
852 Winter Street, Waltham, MA
Signature
/s/ Shantale Greenson, attorney-in-fact for Craig C. Hopkinson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Craig C. Hopkinson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Alkermes plc. EVP R&D, Chief Medical Officer Ordinary Shares 77.7K $2.7M $34.80 Feb 26, 2025 Direct
ALBIREO PHARMA, INC. Director Common Stock 10.5K $460K $43.80 Dec 1, 2022 Direct
Alkermes plc. EVP R&D, Chief Medical Officer Employee Stock Option (Right to Buy) 64K Feb 19, 2025 Direct
Alkermes plc. EVP R&D, Chief Medical Officer Restricted Stock Unit Award 20.6K Feb 26, 2025 Direct
ALBIREO PHARMA, INC. Director Restricted Stock Units 0 Mar 2, 2023 Direct

Insider Reports Filed by Craig C. Hopkinson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALKS Alkermes plc. Feb 26, 2025 3 -$106K 4 Feb 28, 2025 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Feb 22, 2025 6 -$313K 4 Feb 25, 2025 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Feb 18, 2025 5 -$142K 4 Feb 20, 2025 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Feb 12, 2025 12 -$3.59M 4 Feb 14, 2025 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Feb 6, 2025 2 -$473K 4 Feb 7, 2025 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Jan 30, 2025 9 -$1.07M 4 Jan 31, 2025 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Dec 9, 2024 9 -$849K 4 Dec 9, 2024 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Dec 5, 2024 1 -$290K 4 Dec 5, 2024 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Dec 4, 2024 1 -$442K 4 Dec 4, 2024 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Nov 11, 2024 3 -$912K 4 Nov 12, 2024 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Nov 6, 2024 1 -$309K 4 Nov 6, 2024 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Feb 23, 2024 5 -$101K 4 Feb 27, 2024 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Feb 22, 2024 3 -$158K 4 Feb 23, 2024 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Feb 18, 2024 6 -$266K 4 Feb 21, 2024 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Feb 8, 2024 13 $101K 4 Feb 12, 2024 EVP R&D, Chief Medical Officer
ALBO ALBIREO PHARMA, INC. Mar 2, 2023 1 $0 4 Mar 2, 2023 Director
ALKS Alkermes plc. Feb 22, 2023 5 -$148K 4 Feb 24, 2023 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Feb 18, 2023 11 -$449K 4 Feb 22, 2023 EVP R&D, Chief Medical Officer
ALBO ALBIREO PHARMA, INC. Dec 1, 2022 0 $0 3 Dec 5, 2022 Director
ALBO ALBIREO PHARMA, INC. Dec 1, 2022 1 $0 4 Dec 5, 2022 Director
ALKS Alkermes plc. Feb 23, 2022 1 -$297K 4 Feb 24, 2022 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Feb 18, 2022 12 -$272K 4 Feb 23, 2022 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Feb 16, 2022 3 -$28.6K 4 Feb 17, 2022 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Sep 14, 2021 2 -$173K 4 Sep 16, 2021 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Jun 9, 2021 1 -$21.7K 4 Jun 11, 2021 EVP R&D, Chief Medical Officer
ALKS Alkermes plc. Jun 7, 2021 3 -$8.65K 4 Jun 8, 2021 EVP R&D, Chief Medical Officer